title: Neutropenic fever rates with adjuvant docetaxel and cyclophosphamide in early breast cancer: audit from regional cancer centre in New South Wales.
authors.affiliation: Department of Medical Oncology, North Coast Cancer Institute, Coffs Harbour, New South Wales, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: J
authors.initials: J
authors.lastname: Linsell
authors.forename: K
authors.initials: K
authors.lastname: Briscoe
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D054869:Clinical Audit; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D000077143:Docetaxel; D064147:Febrile Neutropenia / Q000139:chemically induced* / Q000517:prevention & control; D005260:Female; D006801:Humans; D009517:New South Wales; D012189:Retrospective Studies; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D003520:Cyclophosphamide